Let-7a is a direct EWS-FLI-1 target implicated in Ewing's Sarcoma development

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  de Vito, Claudio ^a   Riggi, Nicolo ^a   Suvà, Mario Luca ^a   Janiszewska, Michalina ^a   Horlbeck, Janine ^a   Baumer, Karine ^a   Provero, Paolo ^b   Stamenkovic, Ivan ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; PROTEIN LET 7A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; EWS FLI FUSION PROTEIN; EWS-FLI FUSION PROTEIN; MIRNLET7 MICRORNA, HUMAN; ONCOPROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; ENZYME REGULATION; EWING SARCOMA; GENE CLUSTER; GENE REPRESSION; HMGA2 GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL PROLIFERATION; CELL TRANSFORMATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PRECANCER; TUMOR CELL LINE;

MUS;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; MESENCHYMAL STEM CELLS; MICRORNAS; ONCOGENE PROTEINS, FUSION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEIN C-FLI-1; RNA-BINDING PROTEIN EWS; SARCOMA, EWING;

EID: 80051534490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023592     Document Type: Article

References (44)

1. Melo SA, Esteller M, (2011) Dysregulation of microRNAs in cancer: Playing with fire. FEBS Lett 585: 2087-2099.
2. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
3. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591.
4. Plasterk RH, (2006) Micro RNAs in animal development. Cell 124: 877-881.
5. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
6. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
7. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, et al. (2009) A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41: 365-370.
8. Riggi N, Suva ML, De Vito C, Provero P, Stehle JC, et al. (2010) EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 24: 916-932.
9. Riggi N, Stamenkovic I, (2007) The Biology of Ewing sarcoma. Cancer Lett 254: 1-10.
10. Riggi N, Cironi L, Provero P, Suva ML, Kaloulis K, et al. (2005) Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65: 11459-11468.
11. Riggi N, Suva ML, Suva D, Cironi L, Provero P, et al. (2008) EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68: 2176-2185.
12. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, et al. (2007) Mesenchymal stem cell features of ewing tumors. Cancer Cell 11: 421-429.
13. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
14. Bussing I, Slack FJ, Grosshans H, (2008) let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14: 400-409.
15. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
16. Jiang X, Gwye Y, Russell D, Cao C, Douglas D, et al. (2010) CD133 expression in chemo-resistant Ewing sarcoma cells. BMC Cancer 10: 116.
17. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, et al. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41: 843-848.
18. Richter GH, Plehm S, Fasan A, Rossler S, Unland R, et al. (2009) EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc Natl Acad Sci U S A 106: 5324-5329.
19. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, et al. (2008) The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764.
20. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, et al. (2009) Modulation of microRNA processing by p53. Nature 460: 529-533.
21. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, et al. (1997) Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Oncogene 15: 2225-2232.
22. Valastyan S, Weinberg RA, (2010) miR-31: A crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 9.
23. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
24. Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J, et al. (2008) Identification of let-7-regulated oncofetal genes. Cancer Res 68: 2587-2591.
25. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 105: 3903-3908.
26. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME, (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-36.
27. Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, et al. (2008) Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A 105: 10149-10154.
28. Newman MA, Thomson JM, Hammond SM, (2008) Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14: 1539-1549.
29. Viswanathan SR, Daley GQ, Gregory RI, (2008) Selective blockade of microRNA processing by Lin28. Science 320: 97-100.
30. Heo I, Joo C, Cho J, Ha M, Han J, et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276-284.
31. Michlewski G, Caceres JF, (2010) Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nature structural & molecular biology 17: 1011-1018.
32. Fusco A, Fedele M, (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910.
33. Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, et al. (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122: 2233-2241.
34. Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, et al. (2010) Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70: 5923-5930.
35. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
36. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
37. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, et al. (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
38. Droge P, Davey CA, (2008) Do cells let-7 determine stemness? Cell Stem Cell 2: 8-9.
39. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
40. Yang X, Lin X, Zhong X, Kaur S, Li N, et al. (2010) Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells. Cancer Res 70: 9463-9472.
41. Awad O, Yustein JT, Shah P, Gul N, Katuri V, et al. (2010) High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition. PLoS One 5: e13943.
42. Dreux N, Marty M, Chibon F, Velasco V, Hostein I, et al. (2010) Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol.
43. Henriksen J, Stabell M, Meza-Zepeda LA, Lauvrak SA, Kassem M, et al. (2010) Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells. BMC Cancer 10: 329.
44. Nishino J, Kim I, Chada K, Morrison SJ, (2008) Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135: 227-239.